takeda pharmaceutical co ltd
(4502:Tokyo Stock Exchange)
Stephen W. Kaldor Ph.D.
|Age||Total Calculated Compensation||This person is connected to 12 board members in 2 different organizations across 9 different industries.|
See Board Relationships
Dr. Stephen W. Kaldor, also known as Steve, serves as Acting Chief Executive Officer Quanticel Pharmaceuticals, Inc. Dr. Kaldor serves as an Advisor at Thomas, McNerney & Partners and advises on drug discovery. He served as an Advisor of Achaogen, Inc. He is a Venture Partner at Versant Ventures. He was a Venture Partner at Versant Ventures. He gained over 12 years of research and development, drug discovery and development experience at Eli Lilly and Company both as ...
1-1, Doshomachi 4-chomePhone: 81 6 6204 2111
Osaka, -- 540-8645
Fax: 81 6 6204 2880
Board Members Memberships*
Director, Member of Nominating & Governance Committee, Member of Audit Committee and Member of Compensation Committee
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|